Touyun Biotech Group Limited (1332.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 716.14M |
| Enterprise Value | 1.12B |
| P/E Ratio | 2.31 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 6.22 |
| Price/Book Ratio | 3.12 |
| Enterprise/Revenue | 12.96 |
| Enterprise/EBITDA | -34.72 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 3.01 |
| Operating Margin | -0.7 |
AD
Management Effectiveness
| Return On Assets | 0.22 |
| Return On Equity | 4.74 |
Income Statement
| Revenue | 66.97M |
| Revenue/Share | 0.03 |
| Gross Profit | 16.22M |
| EBITDA | -47.87M |
| Net Income | 26.8M |
| Diluted EPS | 0 |
Balance Sheet
| Total Cash | 4.39M |
| Total Cash/Share | 0 |
| Total Debt | 482.12M |
| Total Debt/Equity | 3.41 |
| Current Ratio | 0.15 |
| Book Value Per Share | 0.12 |
Price History
| 52-Week Change | 42.73 |
| 52-Week High | 0.75 |
| 52-Week Low | 0.07 |
| Moving Average 50 Days | 0.15 |
| Moving Average 200 Days | 0.16 |
Statistics
| Average Volume | 1.56M |
| Shares Outstanding | 2.81B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
| Last Split Date | August 12, 2019 |
AD
